Bruce Rogers - Morphic Holding President Officer
President
Bruce Rogers is President Officer of Morphic Holding
Age | 55 |
Phone | 781 996 0955 |
Web | https://www.morphictx.com |
Bruce Rogers Latest Insider Activity
Tracking and analyzing the buying and selling activities of Bruce Rogers against Morphic Holding stock is an integral part of due diligence when investing in Morphic Holding. Bruce Rogers insider activity provides valuable insight into whether Morphic Holding is net buyers or sellers over its current business cycle. Note, Morphic Holding insiders must abide by specific rules, including filing SEC forms every time they buy or sell Morphic Holding'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
Bruce Rogers over six months ago Acquisition by Bruce Rogers of 7400 shares of Morphic Holding at 4.3151 subject to Rule 16b-3 | ||
Bruce Rogers over six months ago Disposition of 7400 shares by Bruce Rogers of Morphic Holding at 4.3151 subject to Rule 16b-3 |
Morphic Holding Management Efficiency
The company has return on total asset (ROA) of (0.1909) % which means that it has lost $0.1909 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.2669) %, meaning that it created substantial loss on money invested by shareholders. Morphic Holding's management efficiency ratios could be used to measure how well Morphic Holding manages its routine affairs as well as how well it operates its assets and liabilities.Morphic Holding currently holds 2.34 M in liabilities with Debt to Equity (D/E) ratio of 0.01, which may suggest the company is not taking enough advantage from borrowing. Morphic Holding has a current ratio of 20.25, suggesting that it is liquid enough and is able to pay its financial obligations when due. Note, when we think about Morphic Holding's use of debt, we should always consider it together with its cash and equity.
Similar Executives
Found 6 records | PRESIDENT Age | ||
Andrew MBA | Vaxcyte | 57 | |
Gregory Zante | Viking Therapeutics | 53 | |
Mark Smythe | Protagonist Therapeutics | 60 | |
Erin MD | Terns Pharmaceuticals | 53 | |
Suneel Gupta | Protagonist Therapeutics | 66 | |
Ashok Bhandari | Protagonist Therapeutics | 61 |
Management Performance
Return On Equity | -0.27 | |||
Return On Asset | -0.19 |
Morphic Holding Leadership Team
Elected by the shareholders, the Morphic Holding's board of directors comprises two types of representatives: Morphic Holding inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Morphic. The board's role is to monitor Morphic Holding's management team and ensure that shareholders' interests are well served. Morphic Holding's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Morphic Holding's outside directors are responsible for providing unbiased perspectives on the board's policies.
MD MBA, CFO COO | ||
Farrell CPA, Sr Officer | ||
Simon MBBS, Chief Officer | ||
Joanne Gibbons, Senior Affairs | ||
CPA Farrell, Senior Officer | ||
Aaron Pelta, Senior Development | ||
Dr MBA, Independent Founder | ||
Bruce Rogers, President Officer | ||
Praveen MD, MD CEO | ||
Timothy Springer, Independent Founder | ||
Blaise Lippa, Chief Officer | ||
William Esq, General Secretary |
Morphic Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Morphic Holding a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Return On Equity | -0.27 | |||
Return On Asset | -0.19 | |||
Current Valuation | 2.24 B | |||
Shares Outstanding | 50.22 M | |||
Shares Owned By Insiders | 17.12 % | |||
Shares Owned By Institutions | 91.02 % | |||
Number Of Shares Shorted | 1.9 M | |||
Price To Earning | (6.19) X | |||
Price To Book | 4.63 X | |||
Price To Sales | 2,753 X |
Currently Active Assets on Macroaxis
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Global Markets Map module to get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes.
Other Consideration for investing in Morphic Stock
If you are still planning to invest in Morphic Holding check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Morphic Holding's history and understand the potential risks before investing.
Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
FinTech Suite Use AI to screen and filter profitable investment opportunities | |
Commodity Directory Find actively traded commodities issued by global exchanges | |
Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins |